Stromelysin-2 is a matrix metalloproteinase that degrades in vitro several
protein components relevant to wound repair such as collagens III and IV, g
elatin, nidogen, laminin-1, proteoglycans, and elastin. Furthermore, it can
activate other matrix metalloproteinases, such as collagenase-1 (matrix me
talloproteinase-1) and collagenase-2 (matrix metalloproteinase-8), as well
as 92 kDa gelatinase. The aim of this study was to determine in a large var
iety of wounds (normally healing dermal and mucosal wounds, suction blister
s, ex vivo cultures, diabetic, decubitus, rheumatic, and venous ulcers) and
keratinocyte cultures, which factors contribute to stromelysin-2 expressio
n and how it is induced in relation to other matrix metalloproteinases. Our
results show that stromelysin-2 mRNA and protein are upregulated later (at
3 d) than matrix metalloproteinase-1 in normally healing wounds and ex viv
o explants, in which stromelysin-2 is invariably expressed by keratinocytes
migrating over dermal matrix. The number of keratinocytes expressing strom
elysin-2 was greatest in chronic inflamed diabetic and venous ulcers compar
ed with rheumatoid and decubitus ulcers, six of which had no signal. In ker
atinocyte cultures, tumor necrosis factor-alpha, epidermal growth factor, a
nd transforming growth factor-beta1 induced stromelysin-2 expression as mea
sured by quantitative reverse transcriptase-polymerase chain reaction, wher
eas different matrices did not upregulate the mRNA. Immunostaining demonstr
ated stromal transforming growth factor-beta1 in contact with the stromelys
in-2-positive keratinocytes. Our results suggest that stromelysin-2 express
ion is important for the normal repair process and is upregulated by cytoki
nes rather than cell-matrix interactions. Stromelysin-2 is most likely to p
articipate in the remodeling of the newly formed basement membrane, and is
not overexpressed in retarded wound healing.